Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings

Lammers Austin; Edmiston Jonathan; Kaestner Victoria; Prasad Vinay

首页> 外文期刊>Mayo Clinic Proceedings >Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings

【24h】

Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings

机译：专家的财务利益和学术影响力代表美国食品和药物管理局的肿瘤药业咨询委员会会议发言

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Mayo Clinic Proceedings》 |2017年第7期|共3页
作者
Lammers Austin; Edmiston Jonathan; Kaestner Victoria; Prasad Vinay;
展开▼
作者单位

Oregon Hlth &

Sci Univ Portland OR 97201 USA;

Oregon Hlth &

Sci Univ Portland OR 97201 USA;

Oregon Hlth &

Sci Univ Portland OR 97201 USA;

Oregon Hlth &

Sci Univ Portland OR 97201 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings [J] . Lammers Austin, Edmiston Jonathan, Kaestner Victoria, Mayo Clinic Proceedings . 2017,第7期

机译：专家的财务利益和学术影响力代表美国食品和药物管理局的肿瘤药业咨询委员会会议发言
2. Potential Financial Bias From Speakers at US Food and Drug Administration's Bone, Reproductive, and Urologic Drugs Advisory Committee Meetings [J] . Johnson Bradley S., Roberts William, Riddle Jonathan, Urology . 2020,第1期

机译：来自美国食品和药物管理局的骨骼，生殖和泌尿药物咨询委员会会议的潜在财务偏见
3. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings. [J] . Lurie P, Almeida CM, Stine N, JAMA: the Journal of the American Medical Association . 2006,第16期

机译：食品和药物管理局药品咨询委员会会议上的财务利益冲突披露和投票方式。
4. RESIDUE EVALUATION OF CERTAIN VETERINARY DRUGS-Joint FAO/WHO Expert Committee on Food Additives:Meeting 2010 - Evaluation of data on ractopamine residues in pig tissues [C] . Joint Food and Agriculture Organization of the United Nations/World Health Organization Expert Committee on Food Additives Meeting . 2010

机译：某些兽药的残留评价 - 粮农组织/世卫组织食品添加剂专家委员会：2010年会议 - 猪组织乳酰胺残留物的数据评价
5. Communicating Data Visually: Data Presentation Formats at U.S. Food and Drug Administration Drug Advisory Committee Meetings. [D] . Smith, Lesley M. 2011

机译：可视化通信数据：美国食品药品监督管理局药品咨询委员会会议上的数据表示格式。
6. Trends in Bone Morphogenetic Protein Usage since the U.S. Food and Drug Administration Advisory in 2008: What Happens to Physician Practices When the Food and Drug Administration Issues an Advisory? [O] . Janay Mckie, Sheeraz Qureshi, James Iatridis, 2014

机译：自2008年美国食品药品监督管理局发布建议以来骨形态发生蛋白的使用趋势：当食品药品管理局发布建议时医师的做法会发生什么？
7. Characteristics and Conflicts of Public Speakers at Meetings of the Oncologic Drugs Advisory Committee to the US Food and Drug Administration [O] . Matthew V. Abola, Vinay Prasad 2016

机译：美国食品和药物管理局肿瘤咨询委员会会议的公共发言人的特征与冲突

Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings

著录项

相似文献

相关主题

期刊订阅